Cargando…
Bilastine for allergic rhinoconjunctivitis, urticaria
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
NPS MedicineWise
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584787/ https://www.ncbi.nlm.nih.gov/pubmed/36382168 http://dx.doi.org/10.18773/austprescr.2022.057 |
Ejemplares similares
-
Critical appraisal of bilastine for the treatment of allergic rhinoconjunctivitis and urticaria
por: Sadaba, Belen, et al.
Publicado: (2013) -
Bilastine: A New Nonsedating Oral H1 Antihistamine for Treatment of Allergic Rhinoconjunctivitis and Urticaria
por: Wolthers, Ole D.
Publicado: (2013) -
Pharmacokinetics and safety of bilastine in children aged 6 to 11 years with allergic rhinoconjunctivitis or chronic urticaria
por: Rodríguez, Mónica, et al.
Publicado: (2020) -
Bilastine in allergic rhinoconjunctivitis and urticaria: a practical approach to treatment decisions based on queries received by the medical information department
por: Leceta, Amalia, et al.
Publicado: (2017) -
Role of bilastine in the management of allergic rhinitis and urticaria: an Asia-Pacific consensus statement
por: Mösges, Ralph, et al.
Publicado: (2016)